Erika L Wood1, Mehrad Adibi1, Wei Qiao2, Jessica Brandt1, Miao Zhang3, Pheroze Tamboli3, Surena F Matin1, Christopher G Wood1, Jose A Karam4. 1. Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas. 2. Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, Texas. 3. Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas. 4. Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas. Electronic address: JAKaram@mdanderson.org.
Abstract
PURPOSE: We examined the incidence, characteristics and treatment of patients with tumor bed recurrence after partial nephrectomy. MATERIALS AND METHODS: We retrospectively reviewed the charts of 2,256 patients with sporadic small renal masses treated with partial nephrectomy between 2000 and 2014. Local tumor bed recurrence was strictly defined as detection of a new enhancing lesion 1) specifically in the surgical defect or 2) in the same region (eg lower pole) as the partial nephrectomy site. To determine differences in multiple characteristics 44 patients (1.9%) with local recurrence were compared to 163 randomly selected patients who underwent partial nephrectomy with no recurrence. RESULTS: Patients with local tumor bed recurrence were more likely to have a solitary kidney (27% vs 4%, p <0.01) and bilateral disease at presentation (23% vs 10.4%, p = 0.02) compared to the group with no recurrence. Positive margins were found in 15.9% of local tumor bed recurrences compared to 3% of the control group (p <0.01). Median time between partial nephrectomy and the detection of local tumor bed recurrence was 23 months (range 2 to 107). Male gender, a solitary kidney at partial nephrectomy, positive surgical margins, multiple tumors, and higher nephrometry score and pathological stage were associated with local tumor bed recurrence. CONCLUSIONS: Local tumor bed recurrence after partial nephrectomy is associated with several preoperative factors, including multiple tumors and a solitary kidney, as well as intraoperative and postoperative factors such as a positive surgical margin and higher pathological stage.
PURPOSE: We examined the incidence, characteristics and treatment of patients with tumor bed recurrence after partial nephrectomy. MATERIALS AND METHODS: We retrospectively reviewed the charts of 2,256 patients with sporadic small renal masses treated with partial nephrectomy between 2000 and 2014. Local tumor bed recurrence was strictly defined as detection of a new enhancing lesion 1) specifically in the surgical defect or 2) in the same region (eg lower pole) as the partial nephrectomy site. To determine differences in multiple characteristics 44 patients (1.9%) with local recurrence were compared to 163 randomly selected patients who underwent partial nephrectomy with no recurrence. RESULTS:Patients with local tumor bed recurrence were more likely to have a solitary kidney (27% vs 4%, p <0.01) and bilateral disease at presentation (23% vs 10.4%, p = 0.02) compared to the group with no recurrence. Positive margins were found in 15.9% of local tumor bed recurrences compared to 3% of the control group (p <0.01). Median time between partial nephrectomy and the detection of local tumor bed recurrence was 23 months (range 2 to 107). Male gender, a solitary kidney at partial nephrectomy, positive surgical margins, multiple tumors, and higher nephrometry score and pathological stage were associated with local tumor bed recurrence. CONCLUSIONS: Local tumor bed recurrence after partial nephrectomy is associated with several preoperative factors, including multiple tumors and a solitary kidney, as well as intraoperative and postoperative factors such as a positive surgical margin and higher pathological stage.
Authors: Ziho Lee; Opeyemi A Jegede; Naomi B Haas; Michael R Pins; Edward M Messing; Judith Manola; Christopher G Wood; Christopher J Kane; Michael A S Jewett; Keith T Flaherty; Janice P Dutcher; Robert S DiPaola; Robert G Uzzo Journal: J Urol Date: 2019-10-09 Impact factor: 7.450
Authors: Hugo Otaola-Arca; Alfred Krebs; Hugo Bermúdez; Raúl Lyng; Marcelo Orvieto; Alberto Bustamante; Conrado Stein; Andrés Labra; Marcela Schultz; Mario I Fernández Journal: Ann Surg Oncol Date: 2022-01-06 Impact factor: 5.344
Authors: Jongsoo Lee; Jinu Kim; Jong Chan Kim; Won Sik Ham; Woong Kyu Han; Koon Ho Rha; Young Deuk Choi; Won Sik Jang Journal: Yonsei Med J Date: 2022-02 Impact factor: 2.759